Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of OXEMET 1000 mg vs GLAFORNIL in Healthy Volunteers
NCT01842620Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01842620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01842620.